title: A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours.
abstract: Dysregulation in post-translational modifications of histones and their modifiers are now well-recognized as a hallmark of cancer and can be used as biomarkers and potential therapeutic targets for disease progression and prognosis. In most solid tumours, a biopsy is challenging, costly, painful or potentially risky for the patient. Therefore, non-invasive methods like 'liquid biopsy' for analysis of histone modifications and their modifiers if possible will be helpful in the better clinical management of cancer patients.
  
  
  
  Here, we have developed a cost-effective and time-efficient protocol for isolation of circulating histones from serum of solid tumor, HCC, called Dual Acid Extraction (DAE) protocol and have confirmed by mass spectrometry. Also, we measured the activity of HDACs and HATs in serum samples.
  
  
  
  The serum purified histones were profiled for changes in histone PTMs and have shown a comparable pattern of modifications like acetylation (H4K16Ac), methylation (H4K20Me3, H3K27Me3, H3K9Me3) and phosphorylation (γ-H2AX and H3S10P) to paired cancer tissues. Profiling for the histone PTM changes in various other organs of normal and tumor bearing animal suggests that the changes in the histone PTMs observed in the tumor serum is indeed due to changes in the tumor tissue only. Further, we demonstrate that the observed hypo-acetylation of histone H4 in tissue and serum samples of tumor bearing animals corroborated with the elevated HDAC activity in both samples compared to normal. Interestingly, human normal and tumor serum samples also showed elevated HDAC activity with no significant changes in HAT activity.
  
  
  
  Our study provides the first evidence in the context of histone PTMs and modifiers that liquid biopsy is a valuable predictive tool for monitoring disease progression. Importantly, with the advent of drugs that target specific enzymes involved in the epigenetic regulation of gene expression, liquid biopsy-based 'real time' monitoring will be useful for subgrouping of the patients for epi-drug treatment, predicting response to therapy, early relapse and prognosis.
authors.affiliation: Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi, Mumbai, 410210 MH India.|Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH 400085 India.
authors.forename: Divya
authors.initials: D
authors.lastname: Reddy
authors.affiliation: Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi, Mumbai, 410210 MH India.
authors.forename: Bharat
authors.initials: B
authors.lastname: Khade
authors.affiliation: Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi, Mumbai, 410210 MH India.
authors.forename: Riddhi
authors.initials: R
authors.lastname: Pandya
authors.affiliation: Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi, Mumbai, 410210 MH India.|Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH 400085 India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Gupta
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood* / Q000302:isolation & purification*; D044127:Epigenesis, Genetic; D051548:Histone Acetyltransferases / Q000097:blood; D042421:Histone Code; D006655:Histone Deacetylases / Q000097:blood; D006657:Histones / Q000097:blood* / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000097:blood*; D011379:Prognosis; D011499:Protein Processing, Post-Translational; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D014408:Biomarkers, Tumor; D006657:Histones; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases
keywords: Cancer; Diagnosis; HDACs; Histones; Serum; cNUC